Stephen Carter
Follow
Get notifications in MyBN when activity occurs.
Stephen Carter
Chief Executive / NeuroScientific Biopharmaceuticals
Most Notable Role
Stephen Carter has over 30 years of experience within the pharmaceutical and medical device industry. He has held a variety of senior positions with multinationals and public-listed companies including roles as chair, chief executive and managing director.
Mr Carter also has extensive contacts and experience in the financial markets and pharmaceutical industry, in investor and investment management, capital raising, business development and partnering, as well as regulatory and corporate compliance across many global jurisdictions.
Mr Carter has been the chief executive of NeuroScientific Biopharmaceuticals since September 2023. He was chair of Hollista Colltech and DelMedica, and managing director of ASX-listed Solbec Pharmaceuticals.
Mr Carter also has extensive contacts and experience in the financial markets and pharmaceutical industry, in investor and investment management, capital raising, business development and partnering, as well as regulatory and corporate compliance across many global jurisdictions.
Mr Carter has been the chief executive of NeuroScientific Biopharmaceuticals since September 2023. He was chair of Hollista Colltech and DelMedica, and managing director of ASX-listed Solbec Pharmaceuticals.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 16th | PharmAust | 331% | 61% |
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 1434th | NeuroScientific Biopharmaceuticals | -48% | -25% |
| 1612th | Nuheara | -60% | -44% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 121st |  | NeuroScientific Biopharmaceuticals | $5.0m |
| 128th |  | PharmAust | $3.8m |
| 129th | | ResApp Health | $3.8m |
| 131st | | Nuheara | $3.8m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Board Moves December 1, 2023 | 01 Dec 2023 |
| NEWS: Tagged in Board Moves August 31, 2023 | 31 Aug 2023 |
| NEW ROLE: Chief Executive, NeuroScientific Biopharmaceuticals | 31 Aug 2023 |
